Levodopa and related drugs.
D000547:Amantadine / Q000627:therapeutic use; D001058:Apomorphine / Q000009:adverse effects; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D007022:Hypotension / Q000139:chemically induced; D001523:Mental Disorders / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010276:Parasympatholytics / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D011736:Pyridoxine / Q000494:pharmacology
D006834:Hydrazines; D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D011736:Pyridoxine; D001058:Apomorphine